BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 21, 2000
View Archived Issues
Progenics expands HIV program with Pharmacopeia, receives SBIR grant
Read More
Phase I trial results presented for IDEC-114 antibody in psoriasis
Read More
Sanofi-Synthelabo presents overhauled R&D portfolio to financial analysts
Read More
New introduction for consensus interferon in major European market
Read More
BMS withdraws NDA for UFT and Orzel, plans to resubmit
Read More
Clinical testing of solid oral dosage form of heparin commences
Read More
Zambon and Sheffield submit IND to FDA for MSI-ipratropium bromide
Read More
Bayer licenses anticancer compound from Indena
Read More
AVI BioPharma successfully completes phase I trials of Resten-NG
Read More
ADIR prepares potent and selective 5-HT1B receptor ligands
Read More
New integrin alphav receptor antagonists patented by Merck
Read More
Lilly discloses new indole sPLA2 inhibitors
Read More
Antimicrobial mutilin derivatives for Gram-positive, Gram-negative and mycoplasmal infections
Read More
Aminomethylcarboxylic acid derivatives as inhibitors of glycine transport
Read More
Novel anticonvulsants continue as area of focus at SB
Read More
Novel class of human 5alpha-reductase inhibitors undergoes evaluation at Yamanouchi
Read More
Zyprexa approved in U.S. for bipolar-associated mania
Read More
LY-293558, a new glutamate receptor antagonist, evaluated for safety and analgesic efficacy
Read More
FDA's ODAC recommends approval of Mylotarg for relapsed AML
Read More
European authorities request comparison studies of dexmedetomidine in ICU
Read More
ASCPT news: pharmacodynamics of VPA-985 + hydrochlorothiazide in humans
Read More
Medinox's NO neutralizer prevents transplant rejection in preclinical study
Read More
Health Canada approves AmBisome as antifungal treatment
Read More
Tarazepide demonstrates activity as CCK-A antagonist in early clinical trials
Read More
Orion licenses deramciclane from Egis and begins phase III program in anxiety
Read More
Korean K+ channel activator SKP-450 has promising PK/PD profile in healthy subjects
Read More
Phase I results for CVT-510 presented at ACR meeting; CV designs new partial agonist derivative
Read More